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Abstract
Unrealistic steady-state assumptions are often used to estimate toxicant exposure rates from biomarkers. A
biomarker may instead be modeled as a weighted sum of historical time-varying exposures. Estimating equations
are derived for a zero-inflated gamma distribution for daily exposures with a known exposure frequency.
Simulation studies suggest that the estimating equations can provide accurate estimates of exposure magnitude at
any reasonable sample size, and reasonable estimates of the exposure variance at larger sample sizes.
Background
Health risks assessment, dietary research, environmental
epidemiology, and other endeavors that depend on
quantitative exposure estimation are increasingly making
use of exposure biomarkers instead of, or in addition to,
traditional contact-based exposure estimates [1-4]. Esti-
mation of exposure rates from biological measurements
is a particularly challenging problem given the complex
relationship between ingested, inhaled, or dermally
absorbed chemical exposures and the resulting tissue
concentrations over time. Indeed, because many differ-
ent exposure patterns can lead to the same blood or
urine concentration at a given point in time, typical
approaches to biomarker based exposure estimation
must rely on simplifying assumptions regarding the
exposure patterns. In cases where exposures have
ceased, such as post-shift or post-retirement studies of
occupational exposures, exposure rates are often reason-
ably assumed to be zero. In other settings, investigators
often rely on an assumption that exposure rates are con-
stant over time for each individual.
Unfortunately, virtually all environmental exposures
vary in magnitude over time, thereby violating the
steady-state model. For example, ingestion occurs inter-
mittently and only during waking hours. These viola-
tions can cause substantial errors in biomarker based
exposure estimates that rely on a steady-state assump-
tion [5]. The degree of error introduced by the steady-
state model is often substantial depending on the elimi-
nation rate of the chemical, the frequency of contact,
and the variability in exposure over time, even under
the highly optimistic assumption that every individual’s
exact biokinetic parameters are known [5-7]. These
results suggest that a substantial portion of observed
population variability in mercury biomarker concentra-
tions may result from non-steady-state exposure condi-
tions, rather than being entirely attributable to true
differences in individual mercury exposure rates. Expo-
sure measurement error is known to cause bias in epi-
demiologic dose response modeling, though post-hoc
methods of adjustment have been proposed [8].
Formal statistical methods for biomarker based expo-
sure estimation that do not rely on steady-state assump-
tions are needed. Standard Monte Carlo simulation
methods have been suggested but are inadequate for
inverse estimation problems due to unknown but non-
zero correlations [9].
We present a new statistical method for estimating
individual exposures to mercury based on individual
hair or blood mercury biomarkers and individual expo-
sure frequencies, for a group of people with the same
probability distribution of daily exposure magnitudes.
Although this method was developed using mercury as
a case study, it may be applicable to other toxicants.
This method avoids steady-state assumptions and incor-
porates information from biokinetic models. The new
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tinuous-time biokinetic models and statistical methods
based on the theory of estimating equations [10,11].
Methods
Simplified Biokinetic Model
The relationship between chemical exposure at the
visible exterior boundary of a person and related bio-
marker measurements is governed by fairly compli-
cated time-dependent processes including absorption
across the skin, gastrointestinal tract, or lung epithe-
lium; distribution throughout the body via blood circu-
lation, filtration, metabolism, and/or sequestering by
liver and kidneys; and excretion via skin, nails, hair,
urine, and feces. The entire system of these processes
is referred to as “pharmacokinetics,”“ toxicokinetics,”
or “biokinetics.”
Mathematically, biokinetic models are typically com-
posed of continuous-time systems of differential equa-
tions, with each differentiale q u a t i o nr e p r e s e n t i n gt h e
rate of change in concentration or mass of a chemical in
a particular tissue or organ as the chemical is exchanged
with blood, metabolized, or excreted. These biokinetic
models are generally not invertible without additional
constraints and ad hoc methods, due to the dimensional
reduction from continuous-time exposure patterns to
biomarker measurements at specific time points. In
other words, many different exposure patterns can lead
to the same biomarker concentration, so it is generally
not possible to determine an exact exposure pattern
using only biomarker measurements. Instead, biomarker
based risk assessments typically rely on the simplifying
but unrealistic steady-state assumption, multiplying each
individual’s biomarker concentration by a steady-state
ratio in order to estimate constant exposure rates.
The classic single compartment biokinetic model can
be expressed as a differential equation:
∂y(t)
∂t
=
fI(t)
v
− ky(t),
where y(t) is the biomarker concentration at time t, f is
the fraction of ingested mercury present in the blood
after absorption across the gastrointestinal tract and
equilibration throughout the body, v i st h ev o l u m eo f
blood, I(t)i st h em e r c u r ye x p o s u r er a t ea tt i m et,a n dk
is the excretion rate coefficient for mercury. If I(t)i s
constant then y(t) eventually reaches “steady-state,” i.
e.,
∂y(t)
∂t
→ 0 and y →
fI
kv. Thus, the steady-state ratio of I
to y is b =
kv
f . An estimate of this steady-state ratio is
typically multiplied by each individual’sm e a s u r e db i o -
marker concentration in order to estimate the corre-
sponding exposure rate.
It is more difficult to develop general solutions and
frequentist statistical approaches for the single-
compartment model under non-steady state conditions.
One approach is to use a discrete-time approximation
to the continuous-time single compartment biokinetic
model [5,12]. This approach allows for formal statistical
estimation and incorporates key biokinetic features of
t h es i n g l ec o m p a r t m e n tc o n t i n u o u s - t i m em o d e l ,w h i l e
avoiding the unrealistic steady-state assumption. For
example, the blood mercury concentration in a person
exposed to mercury over a period of time, t,m a yb e
approximated by:
yit =
t 
j=1
IijWijt + εit (1)
where yit is the blood mercury concentration in indivi-
dual i on day t, Iij is the mercury intake for individual i
on day j, Wijt is the “weight” or influence of the day j
intake on the day t biomarker measurement in indivi-
dual i, and εit is a statistical error term with expectation
0 and variance sε
2. Wijt expresses the short term absorp-
tion and dilution of the mercury into the blood, as well
as the elimination of mercury from the body over time.
As noted by Sherlock et al. [12] in their least squares
estimation of biokinetic parameters from a controlled
dosing study, Equation 1 provides a close approximation
to a continuous-time one-compartment biokinetic mer-
cury model with first order elimination, provided that
Wijt =
fi
vi
e−ki(t−j),w h e r efi is the fraction of ingested mer-
cury present in the blood of individual i after absorption
across the gastrointestinal tract and equilibration
throughout the body, vi is the volume of blood in indivi-
dual i,a n dki is the excretion rate coefficient for mer-
cury. For chronic exposures t should be chosen to
reflect at least ten half-lives, but needn’ti n c l u d et h e
entire individual history as the earliest exposures will
have negligible contributions to the measured biomarker
concentration.
A similar approximation can be used for segmental
hair analysis:
zit1t2 =
t2 
j=1
IijWijt1t2 + ζit1t2, (2)
where zit1t2 is the hair mercury concentration in indi-
vidual i in the hair segment grown between days t1 and
t2, Wijt1t2 is the influence of the day j intake on the hair
segment mercury concentration, and ζit1t2 is a statistical
error term with expectation 0 and variance sξ
2. The dis-
crete model described by Equation 2 is a close approxi-
mation to an appropriate continuous-time biokinetic
model with the following expression for the exposure
weights:
Bartell and Johnson Environmental Health 2011, 10:57
http://www.ehjournal.net/content/10/1/57
Page 2 of 10Wijt =
hifi

e−ki(t1−j)1{j<t1} − e−ki(t2−j+1)
vi

1 − e−ki

(t2 − t1 +1 )
,
where hi is the equilibrium ratio for hair to blood in
individual i [5,13].
Probability Model for Daily Exposures
Equations 1 and 2 can be used along with modern sta-
tistical methods to estimate exposure characteristics
from biomarker measurements without imposing
steady-state assumptions. For example, the following
mixture probability density function allows for intermit-
tent exposures with gamma distributed exposure magni-
tudes:
f(Iij)=(1 − ωi)1{Iij=0} + ωi
λaIij
a−1e−λIij
  (a)
1{Iij>0} (3)
where ωi is the exposure frequency (with units of day
-
1), 1{S} is an indicator function that takes the value 1
when statement S is true and 0 otherwise, and a and l
are parameters describing the gamma distribution.
Unlike the lognormal distribution, the gamma distribu-
tion can take on a heavily skewed shape or a nearly
symmetric shape depending on the values of the two
parameters. Here we assume that exposures are inde-
pendent across days and across individuals. This inde-
pendence assumption may not be reasonable for
individuals who share meals, or for those who obtain
multiple meals from the same source item. For example,
a person consuming many tuna steaks all cut from the
same individual fish should have highly correlated mer-
cury exposures over time.
One important attribute of the zero-inflated gamma
distribution shown in Equation 3 is that its expectation
and variance are easily computed: E(Iij)=
ωia
λ and
Var(Iij)=ωi
a
λ
+
a
λ2

− ω2
i
a
λ2. For our proposed estimation
method, it is useful to reparameterize the zero-inflated
gamma distribution using α =l n
a
λ2 and β =l n
a
λ . a and b
are the log variance and log mean of the conditional
exposure distribution, for days with non-zero exposures.
The expectation and variance of the unconditional expo-
sure distribution can then be written as and
Var(Iij)=ωi

eβ + eα
− ω2
i eα. We will estimate a and b
rather than a and l. This parameterization has two
important advantages: 1.) a and b are unrestricted on
the real number line and 2.) E(Iij) has only one
unknown parameter when individual exposure frequen-
cies can be measured, e.g. by food frequency
questionnaires.
In this model all methylmercury exposures within a
day are grouped together, so the exposure frequency
cannot exceed 1 per day. Although the daily grouping of
exposures represented by Equations 1-3 does not cap-
ture the full complexity of the exposure profile, the
approach is much more realistic than the assumption of
constant mercury exposure, is amenable to formal statis-
tical treatment, and can easily be extended to include
fixed covariate effects.
We have chosen to group exposures by day, but our
model is easily adjusted for grouping into smaller (or
larger) time intervals, provided that the biokinetic model
weights are selected appropriately. For the best approxi-
mation, interval lengths should be small relative to the
biological half life of the toxicant being modeled. For
example, many solvents are quickly excreted from the
body; one day exposure aggregates for these compounds
would be too crude to compare with biomarker concen-
trations, but one to sixty minute intervals might prove
reasonable.
Results
I nt h ec a s eo fe x p o s u r ee s t imation using biomarker
measurements alone, the models formulated by combin-
ing the above equations pose a challenge in that the
likelihood equations are difficult to obtain due to the
convolution of many mixture distributions containing
both discrete and continuous components. We first
explored normal approximations to the summation in
Equation 1, but simulation studies indicate that normal-
i t yo n l yh o l d sw h e nt h ee x p o s u r ef r e q u e n c yi sh i g hand
the variance in daily exposure magnitudes is low, mak-
ing the normal approximation and classical statistical
methods unsuitable for most realistic exposure settings
[13]. Instead, we propose estimating equations based on
the quasi-likelihood [11]. The estimating equations rely
entirely on the expectation and variance of the biomar-
ker measurements in terms of the unknown exposure
parameters, bypassing the need for an explicit likelihood
equation or even specification of exact probability
distributions.
Algorithm
Estimating equations, particularly in the form of gener-
alized estimating equations [14], have become popular
in situations where it is difficult to model complex data,
such as correlated data that do not arise from a multi-
variate normal distribution [11,15]. Although estimating
equations do not appear to have been previously applied
to non-steady-state biomarker based exposure estima-
tion, the method is quite flexible and appears to be reli-
able in this setting.
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“quasi-score function” [10,16]. Consider an n ×1
response vector Y with expectation vector EY and cov-
ariance matrix V.L e tE Y b eaf u n c t i o no fa nu n k n o w n
p-parameter vector b, and D be the n × p matrix
∂(EY)
T
∂β
.
The quasi-score function is the p × 1 vector.
Under certain conditions “quasi-likelihood” estimation
using the quasi-score function shares several key proper-
ties with a true likelihood based score function, resulting
in similar asymptotic properties to those for maximum
likelihood estimates [16]. Quasi-likelihood estimates are
obtained by setting each element of the quasi-score
function equal to 0 and solving for each element in the
vector b. These equations are referred to as estimating
equations. In practice, the Newton-Raphson method
with Fisher scoring is typically used to solve the estimat-
ing equations:
ˆ βl+1 = ˆ βl + ( ˆ Dl
T ˆ Vl
−1 ˆ Dl)−1 ˆ Dl
T ˆ Vl
−1
(Y − ElY) (4)
starting with ˆ β0,a ni n i t i a lg u e s sf o rb. ˆ Dl
T, ˆ Vl,a n dE 1Y
are the lth iterate estimates of D, V, and EY, respectively,
and are all obtained by evaluation at ˆ β1.T h ea l g o r i t h m
consists of repeated application of Equation 4, incre-
menting l by 1 each time, until ˆ β1+1 and ˆ β1 only differ
by a prespecified negligible amount, at which point ˆ β1
has usually converged to the root ˆ β of the estimating
equations.

ˆ D
T
l ˆ V
−1
l ˆ Dl
−1
is an estimate of the covariance
of ˆ β , and is easily obtained directly from the algorithm.
Although we do not show it here, Equation 4 can usually
be written in a more computationally efficient form
involving summations of block diagonal elements [15].
In a simple biomarker application, Y might represent
statistically independent blood mercury measurements
yit for i = 1, 2, ..., n individuals, with one measurement
per person. Assume that Equations 1-3 apply and that
each individual’s biokinetic parameters ki, fi,a n dvi and
exposure frequency ωi are known. Using Equations 1-3,
basic mathematical properties of expectations and var-
iances of weighted sums [17], and summation rules for
finite geometric series, the vector EY consists of the n
elements ωieβ fi
vi
1 − e−kit
1 − e−ki , i = 1, 2, ..., n, and V is a diagonal
matrix with diagonal entries
σε
2 +

ωi

eα + e2β
− ωi
2e2β fi
2
vi
2
1 − e−2kit
1 − e−2ki . [13]. In this case, p =
1 because there is only one unknown parameter b in
the mean vector EY. Conveniently, here D =E Y.
In most cases, including our model for biomarkers, V
depends on additional unknown parameters other than
b. These additional parameters are denoted by a–as c a -
lar in our model, as there is only one unknown variance
parameter not contained in the mean vector. There are
several different strategies for estimating both a and b,
but the most reliable appears to be the use of alternat-
ing estimating equations, whereby a second estimating
equation is written for a, and the algorithm proceeds
with alternating iterative estimation of a and b [13,15].
The estimating equation for a c a nb ew r i t t e na s
ˆ D∗T ˆ V∗−1(s −ˆ σ),w h e r eˆ σ is the upper diagonal of the
estimated covariance matrix ˆ V in vector form as

ˆ V11, ˆ V12,..., ˆ V1n, ˆ V22,..., ˆ V2n, ˆ V33..., ˆ Vnn
T
, s is an “empirical
covariance vector” with (n
2+n)/2 elements sij =( Yi -E Yi)
(Yj -E Yj) corresponding to the elements of ˆ σ, ˆ D∗ is the
(n
2+n)/2 length vector of estimates for
∂σ
∂α
,a n d ˆ V∗ is
the (n
2+n)/2 x (n
2+n)/2 estimated covariance matrix for
the vector s.
When the observations are independent (a reasonable
assumption for one measurement per person), V is a
diagonal matrix and many of the elements of ˆ V∗ are 0.
In this special case, the estimating equations for a can
be simplified using ˆ σ =

ˆ V11, ˆ V22,..., ˆ Vnn
T
with a corre-
sponding n length vector for s,a nn length vector for
ˆ D∗,a n da nn x n matrix for ˆ V∗. In either case, an
iterative equation analogous to Equation 4 can be
derived from the estimating equations for a.B e c a u s e
there is only one measurement per person, this method
relies on the between-subject variability in biomarker
measurements for estimation of a. This approach is rea-
sonable when subjects have similar exposure sources
(e.g., similar types of fish in the diet).
The elements of the vector D* are easily obtained as
ωieα fi
2
vi
2
1 − e−2kit
1 − e−2ki . An expression for V* is more difficult to
obtain without simplifying assumptions. We employ the
“independence working matrices” assumption of Pre-
ntice and Zhao [15], approximating the elements of V*
based on a simplifying assumption of independence and
normality among the elements of Y. For one measure-
ment per person, this assumption results in a diagonal
matrix for V*, with elements (2V11,2 V22, ..., 2Vnn). In
the case of multiple measurements per person, V* is
block diagonal with covariance terms of ViiVjj for mea-
surements at different time points in the same indivi-
dual. Though these can be crude approximations for V*,
resulting estimates of a and b remain theoretically valid
and appear to be reliable at reasonable sample sizes.
It is impossible to estimate both a and σε
2 from the
data alone with only one biomarker measurement per
person; in this setting an external estimate of one of the
two parameters is needed. In other words, one needs to
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sure magnitude over time, or 2.) the variance of any
random errors resulting from sources other than expo-
sure variability (e.g., biomarker measurement error and
natural biokinetic variation across individuals. Collecting
multiple biomarker measurements per individual may
reduce or eliminate the need for specifying external
parameter estimates for a or σε
2.
Testing and Implementation
In order to examine the performance of the estimating
equations under simple conditions, we conducted sev-
eral simulation studies for the simple setting described
above, with only one blood measurement per individual.
We generated 10,000 data sets at each of 9 different
exposure frequencies and 10 different sample sizes ran-
ging from 2 to 1024. For simplicity we assigned all indi-
viduals the same biokinetic parameters throughout the
simulations, using the values fi = 0.0475, vi = 5 L, and ki
= 0.014 d
-1 [1,18] for all i, and assumed that sε
2 was
known and relatively small. For ease of interpretation
we present results in terms of the mean exposure mag-
nitude, μ = e
b, and the variance in exposure magnitudes,
σ2
g = eα. All simulations were performed using μ =1 0
μgd
-1, sg
2 =5μg
2 d
-2, sε
2 =0 . 0 3
2 μg
2 d
-2, and t = 1000
d. The algorithm only failed to converge for a few simu-
lated data sets with both low exposure frequency and a
sample size less than 10; for the worst case with n = 2
and an exposure frequency of 0.1 the algorithm con-
verged for about 99.4% of the simulated data sets.
Results with regard to potential bias are shown in
Figures 1 and 2, and in Tables 1 and 2. Figure 1 sug-
gests that the estimating equations produce unbiased
estimates of μ regardless of exposure frequency when
the model is correctly specified, even if sample sizes are
very small. Estimates of sg
2 may be biased at small sam-
ple sizes, however, as shown in Figure 2 and Table 2. At
small exposure frequencies in particular, sg
2 tends to be
overestimated at sample sizes less than about 100
individuals.
Figures 3 and 4 show the mean squared errors for the
estimates of μ and sg
2, respectively. These results show
good accuracy of the estimates of μ at sample sizes of at
least 20 for all exposure frequencies, and good accuracy
at even smaller sample sizes for larger exposure fre-
quencies. In contrast, a large sample size may be
required to ensure that sg
2 is estimated accurately by a
single study.
95% confidence intervals were also constructed for μ
and sg
2 using the estimated covariances from the simu-
lations, assuming approximate normality of the
2 5 10 20 50 100 200 500 1000
9
.
9
5
1
0
.
0
0
1
0
.
0
5
1
0
.
1
0
sample size
μ
^
ω=0.1
ω=0.2
ω=0.3
ω=0.4
ω=0.5
ω=0.6
ω=0.7
ω=0.8
ω=0.9
Figure 1 Mean estimate of the mean exposure magnitude, μ, using 10,000 simulated data sets with μ = 10, sg
2 = 5, and the estimating
equations method. Results are shown for nine different values of the exposure frequency (ω) and ten different sample sizes (n).
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tion of the 95% confidence bounds for b and a). Table
3 shows the actual coverage rates for nominal 95% con-
fidence intervals for μ at each simulated exposure fre-
quency and sample size. Coverage rates are generally
close to the nominal 95% value for μ, though they were
as low as 91% in some cases for sample sizes less than
5. In contrast, coverage rates for sg
2 exceeded 99% for
all simulated conditions, indicating that the confidence
intervals for sg
2 are overly conservative. The reasons for
this are unclear, but may be due to the crude approxi-
mation of V* used in our algorithm and/or apparent
departures from normality. Further methodological work
may be useful if sg
2 is an important target for hypoth-
esis testing and inference, in addition to estimation.
Discussion
The simulation studies indicate that the estimating
equations are quite reliable for estimation of mean
exposure magnitudes even at fairly low sample sizes, but
Table 1 Bias in estimation of the mean exposure magnitude, μ
Exposure Frequency
Sample Size 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
2 0.033 0.024 -0.021 -0.008 -0.007 -0.003 -0.002 0.005 0
4 0.002 -0.007 0.017 -0.002 0.006 0.007 0.002 0.004 -0.005
8 0.01 0.004 -0.004 0.013 -0.001 -0.001 0.001 0.003 -0.001
16 0.008 -0.001 0.003 0.007 0 0 0.001 0.001 -0.001
32 0.001 0.004 0.003 0.007 -0.001 0.003 0.001 0.002 -0.001
64 0.007 0.004 0.003 0.005 -0.003 0 0 0.001 -0.001
128 0.005 0.004 0.002 0.007 -0.002 0.001 0 0.001 -0.001
256 0.006 0.003 0.001 0.005 -0.001 0.001 0.001 0.001 -0.001
512 0.004 0.001 0.002 0.007 -0.002 0.001 0.001 0.001 -0.001
1024 0.004 0.002 0.002 0.007 -0.002 0 0 0.001 0
2 5 10 20 50 100 200 500 1000
0
5
1
0
1
5
2
0
sample size
σ
g
^
2
ω=0.1
ω=0.2
ω=0.3
ω=0.4
ω=0.5
ω=0.6
ω=0.7
ω=0.8
ω=0.9
Figure 2 Mean estimate of the variance in exposure magnitudes, sg
2, using 10,000 simulated data sets with μ = 10, sg
2 = 5, and the
estimating equations method. Results are shown for nine different values of the exposure frequency (ω) and ten different sample sizes (n).
Bartell and Johnson Environmental Health 2011, 10:57
http://www.ehjournal.net/content/10/1/57
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cult to estimate at low sample sizes when the exposure
frequency is low. Confidence intervals are also readily
obtained and reasonable accurate for mean exposure
magnitudes, but may be overly conservative for the var-
iance in exposure magnitudes.
It is worth noting that the steady-state method
assumes a constant exposure rate, implying that the
exposure frequency is 100% and that the exposure var-
iance is 0. Observed between-individual variability in
biomarker measurements is therefore assumed to reflect
true individual differences in exposure rates, rather than
day-to-day variability in exposures. The steady-state
method has previously been shown to be imprecise in
estimating individual exposure rates when day-to-day
variability exists [5]. If the correct value is used for the
steady-state ratio b, the steady-state method estimates μ
with a bias of E
	yi
b
− μ


= μ

ωiki
1 − e−kit
1 − e−ki − 1

and a preci-
sion of Var
	yi
b


=
v2
i k2
i σ2
ε
f2
i
+

ωiσ2
g + ωiμ2 − ω2
i μ2

k2
i
1 − e−2kit
1 − e−2ki
when applied to an individual with non-steady-state
zero-inflated exposures [13]. In our simulation setting,
the bias of the steady-state estimate for μ is therefore
approximately 10(ωi - 1) and the variance of the steady-
state estimate (for each individual) is approximately
−0.710ω2
i + 0.745ωi +0 . 0 0 2. Thus, the standard errors
for the steady-state estimate range from 0.26 to 0.44 in
our simulation setting. Although the estimating equa-
tions appear to produce unbiased estimates for μ in
nearly all of our simulations, clearly outperforming the
steady-state estimate at all nine exposure frequencies in
Table 2 Bias in estimation of the variance in exposure
magnitudes, sg
2
Exposure
Frequency
Sample Size 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
2 5.34 5.9 4.8 3.36 2.89 1.27 0.3 -0.82 -1.83
4 10.22 8.55 6.89 6.05 4.74 3.11 1.96 0.26 -0.96
8 9.22 8.49 6.89 5.48 4.56 2.91 1.75 0.41 -0.56
16 7.6 6.31 5.29 4.45 3.07 2.38 1.07 0.09 -0.4
32 5.36 4.56 3.44 2.56 2.31 1.43 0.54 -0.02 -0.35
64 3.38 2.88 2.21 1.69 1.39 0.92 0.17 -0.12 -0.17
128 2.09 1.58 1.32 0.77 0.68 0.36 -0.03 -0.19 -0.06
256 0.95 0.72 0.61 0.44 0.31 0.18 -0.1 -0.09 0
512 0.43 0.31 0.2 0.14 0.22 0.21 -0.13 -0.09 0.02
1024 -0.05 0.06 -0.03 0.01 0.19 0.16 -0.08 -0.04 0.04
2 5 10 20 50 100 200 500 1000
0
1
2
3
4
sample size
M
S
E
 
μ
^
ω=0.1
ω=0.2
ω=0.3
ω=0.4
ω=0.5
ω=0.6
ω=0.7
ω=0.8
ω=0.9
Figure 3 Mean squared errors for estimates of the mean exposure magnitude, μ, using 10,000 simulated data sets with μ = 10, sg
2 =
5, and the estimating equations method. Results are shown for nine different values of the exposure frequency (ω) and ten different sample
sizes (n).
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Page 7 of 10this setting, it is worth noting that a simple modification
of the steady-state estimator from
yi
b to
yi
bωi produces
nearly unbiased estimates for large t, and averaging
those estimates for groups of individuals with similar
exposure sources would improve the precision of the
estimate of μ. With these modifications, the steady-state
method might be a reasonable approach for estimating
group-averaged exposure rates when the exposure
duration is long, provided that exposure variability is
only a nuisance instead of a target for estimation.
Unlike steady-state methods, the estimating equations
provide estimates and standard errors for both exposure
magnitude parameters when sε
2 is negligible or can be
estimated from external data. Statistical theory and our
simulations suggest that the estimating equations esti-
mates of b have approximately normal distributions at
sample sizes above 20 or 30. At high exposure frequencies,
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Figure 4 Mean squared errors for estimates of the variance in exposure magnitudes, sg
2, using 10,000 simulated data sets with μ =
10, sg
2 = 5, and the estimating equations method. Results are shown for nine different values of the exposure frequency (ω) and ten
different sample sizes (n).
Table 3 Coverage of nominal 95% confidence intervals for the mean exposure magnitude, μ
Exposure Frequency
Sample Size 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
2 94.5% 94.7% 94.8% 94.8% 94.3% 94.0% 94.1% 93.7% 91.0%
4 94.9% 95.0% 94.8% 95.0% 94.8% 94.6% 94.7% 93.8% 91.9%
8 95.3% 95.5% 94.9% 95.2% 94.9% 94.4% 94.6% 94.4% 93.2%
16 95.3% 95.3% 95.2% 94.9% 95.2% 94.9% 94.8% 94.0% 93.4%
32 95.1% 95.5% 95.3% 95.1% 95.1% 94.7% 94.8% 94.4% 94.2%
64 95.1% 95.2% 95.7% 94.8% 94.9% 94.5% 94.5% 94.5% 94.3%
128 95.2% 94.9% 95.1% 95.1% 95.2% 94.6% 94.8% 94.4% 94.9%
256 95.2% 95.1% 95.2% 94.9% 95.1% 95.2% 94.9% 95.0% 94.9%
512 95.5% 95.3% 95.2% 94.5% 94.9% 94.8% 94.8% 95.0% 95.4%
1024 95.1% 94.9% 95.0% 94.3% 95.2% 95.2% 94.9% 94.9% 94.7%
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Page 8 of 10even fewer biomarker samples may be necessary in order
for the estimates to be normal. Unfortunately, estimates of
a generated in the simulation studies exhibited fairly
strong departures from normality even with hundreds of
samples, suggesting that the usual asymptotic normal con-
fidence intervals for a might not be appropriate for typical
biomarker studies. If confidence intervals for a are desired,
jackknife or bootstrap procedures might provide more
accurate results. However, such estimates still depend on
the correct specification of sε
2. If variability in daily expo-
sure magnitudes is an important target for inference, we
recommend that multiple biomarker measurements be
obtained for each individual. Carefully structured repeated
biomarker measurements and duplicate samples may pro-
vide a means to simultaneously estimate both a and sε
2.
It is possible to extend the estimating equations to
handle multiple biomarkers per individual. For example,
to extend the simple model to the case with two bio-
markers per individual collected at times t1 and t2,t h e
biomarker vector Y is doubled in length, EY is identical
for each pair of measurements from the same individual,
and V becomes larger due to the additional elements
describing the covariance between repeated measure-
ments in the same individual [13]:
cov

yit1,yit2

=

ωi

eα + e2β
− ωi
2e2β
∗
fi
2
vi
2
1 − e−2kit1
1 − e−2ki e−k(t2−t1).
Further study is needed to determine whether this
approach or alternatives such as population-averaged
generalized estimating equations are more reliable in
this setting.
Incorporation of interindividual variability in the bio-
kinetic parameters is another goal for extension of these
methods. Although additional variance parameters
would be difficult to estimate with only one measure-
ment per person, biokinetic parameters that vary across
individuals but are stable over time might be estimable
from repeated biomarker measurements. In principle
these extensions might be accomplished using estimat-
ing equations, but Bayesian approaches become more
attractive with increasing model complexity [13].
Conclusions
Direct exposure measurements such as those obtained
by duplicate diet studies are often prohibitively expen-
sive for chronic exposure situations such as mercury
exposure via ordinary seafood consumption. Indirect
estimation using exposure biomarkers is an informative
and less expensive approach, but such an exercise
should be recognized as a statistical problem whereby
the unknown exposure parameters are estimated based
on a theoretical model relating the unknown exposures
to the observed biomarker measurements.
Our proposed estimating equation approach to bio-
marker based exposure assessment represents a compro-
mise between the steady-state model, which is overly
simplistic but still widely used because of its practicality,
and fully detailed biokinetic models that are somewhat
impractical for use in formal statistical estimation with
ongoing exposures. Our methods have some clear
advantages for mercury exposure estimation compared
to the steady-state model, due to the more realistic
model and the ability to do hypothesis testing and statis-
tical inference. We also believe it may be a valid
approach for other chemicals exhibiting first-order bio-
kinetics, provided that the discrete-time unit length is
selected to be short relative to the biological half-life.
However, its current implementation is based on some-
what restrictive assumptions, including that biokinetic
parameters are known and constant across individuals,
that measurement error is negligible or can be estimated
externally, that individuals can be grouped according to
similar exposure distributions, that exposures are inde-
pendent across days and individuals, and that individual
exposure frequencies can be accurately measured.
Future work should assess the performance of both
steady-state and non-steady-state methods when these
assumptions are violated, as well as extending these
methods towards less restrictive assumptions.
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